These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16040085)

  • 41. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
    Chen DJ; Falzarano SM; McKenney JK; Przybycin CG; Reynolds JP; Roma A; Jones JS; Stephenson A; Klein E; Magi-Galluzzi C
    BJU Int; 2015 Aug; 116(2):220-9. PubMed ID: 25060664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes?
    Thong AE; Shikanov S; Katz MH; Gofrit ON; Eggener S; Zagaja GP; Shalhav AL; Zorn KC
    J Urol; 2008 Dec; 180(6):2436-40. PubMed ID: 18930486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
    BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.
    Miyamoto H; Hernandez DJ; Epstein JI
    Hum Pathol; 2009 Dec; 40(12):1693-8. PubMed ID: 19683331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology.
    Hautmann SH; Conrad S; Henke RP; Erbersdobler A; Simon J; Straub M; Graefen M; Hautmann RE; Huland H
    J Urol; 2000 Jun; 163(6):1734-8. PubMed ID: 10799171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?
    Kunju LP; Daignault S; Wei JT; Shah RB
    Hum Pathol; 2009 Apr; 40(4):558-64. PubMed ID: 19144380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative prediction of pathologically insignificant prostate cancer in radical prostatectomy specimens: the role of prostate volume and the number of positive cores.
    Raventós CX; Orsola A; de Torres I; Cecchini L; Trilla E; Planas J; Morote J
    Urol Int; 2010; 84(2):153-8. PubMed ID: 20215818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of minute focus of adenocarcinoma on prostate needle biopsy.
    Samaratunga H; Yaxley J; Kerr K; McClymont K; Duffy D
    Urology; 2007 Aug; 70(2):299-302. PubMed ID: 17826493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of cancer in radical prostatectomy specimens with no residual carcinoma in the initial review of slides.
    Duffield AS; Epstein JI
    Am J Surg Pathol; 2009 Jan; 33(1):120-5. PubMed ID: 18971774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness.
    Loeb S; Sutherland DE; D'Amico AV; Roehl KA; Catalona WJ
    Urology; 2008 Nov; 72(5):1116-20; discussion 1120. PubMed ID: 18571700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies.
    Kassouf W; Nakanishi H; Ochiai A; Babaian KN; Troncoso P; Babaian RJ
    J Urol; 2007 Jul; 178(1):111-4. PubMed ID: 17499289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of extraprostatic extension in men with biopsy Gleason score of 8 or greater.
    Nakanishi H; Troncoso P; Babaian RJ
    J Urol; 2008 Dec; 180(6):2441-5; discussion 2445-6. PubMed ID: 18930495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
    Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
    Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Saturation biopsy improves preoperative Gleason scoring of prostate cancer.
    Kahl P; Wolf S; Adam A; Heukamp LC; Ellinger J; Vorreuther R; Solleder G; Buettner R
    Pathol Res Pract; 2009; 205(4):259-64. PubMed ID: 19106019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.
    Epstein JI; Walsh PC; Sauvageot J; Carter HB
    J Urol; 1997 Nov; 158(5):1886-90. PubMed ID: 9334623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.
    Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
    J Urol; 2004 Mar; 171(3):1089-92. PubMed ID: 14767277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy.
    Sinnott M; Falzarano SM; Hernandez AV; Jones JS; Klein EA; Zhou M; Magi-Galluzzi C
    Prostate; 2012 Aug; 72(11):1179-86. PubMed ID: 22161896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostate cancer volume at biopsy predicts clinically significant upgrading.
    Dong F; Jones JS; Stephenson AJ; Magi-Galluzzi C; Reuther AM; Klein EA
    J Urol; 2008 Mar; 179(3):896-900; discussion 900. PubMed ID: 18207180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A clinicopathologic study of preoperative and postoperative findings with minute Gleason 3+3=6 cancer at radical prostatectomy.
    Osunkoya AO; Carter HB; Epstein JI
    Urology; 2008 Sep; 72(3):638-40. PubMed ID: 18400278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.